Search - tctmd.com

Displaying 941 - 960 of 1152

Sort: Relevancy | Date

News Industry News

Sorin Group Announces CE Mark Approval for CROWN PRT(TM) Heart Valve

July 24, 2014

News Daily News

La Trombólisis Dirigida por Cateter para el Manejo de la TVP Aumenta las Hemorragias comparado con la Anticoagulación Estándar

L.A. McKeown

July 24, 2014

News Daily News

DVT导管溶栓术的出血风险比标准坑凝血方法高

L.A. McKeown

July 24, 2014

News Daily News

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

L.A. McKeown

July 24, 2014

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

News Industry News

Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion

July 17, 2014

News Daily News

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

L.A. McKeown

July 03, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

July 02, 2014

News Daily News

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

Yael L. Maxwell

June 27, 2014

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

News Daily News

EVAR Safer Than Surgery Even in Low-Risk Men

June 27, 2014

News Daily News

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

Yael L. Maxwell

June 24, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban as Good as Warfarin in Elderly Patients

June 11, 2014

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

News Daily News

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

Jason Kahn

May 15, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

Advertisement

Sorin Group Announces CE Mark Approval for CROWN PRT(TM) Heart Valve

La Trombólisis Dirigida por Cateter para el Manejo de la TVP Aumenta las Hemorragias comparado con la Anticoagulación Estándar

DVT导管溶栓术的出血风险比标准坑凝血方法高

Catheter-Directed Thrombolysis for DVT Increases Bleeding Compared With Standard Anticoagulation

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

La Dosis Alta de Edoxaban es Igual de Eficaz que la Warfarina en la Prevención de ACV por FA

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

EVAR Safer Than Surgery Even in Low-Risk Men

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

ROCKET AF Substudy: Rivaroxaban as Good as Warfarin in Elderly Patients

Benefit of LAA Closure Becomes Most Evident After 1 Year

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content